AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimbeat M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Brivan Biotech Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimbeat M 1mg/500mg Tablet

Diabeticard Duo 1mg/500mg tablets are classified as antidiabetic medications, a dual-drug formulation for adult type 2 diabetes management. They help regulate blood glucose. Diabeticard Duo should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial; premature discontinuation, without consulting your doctor, can elevate blood sugar, increasing the risk of complications like kidney impairment, vision loss, neuropathy, and limb amputation. This medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as advised by your healthcare provider. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential to manage this. Alcohol should be avoided due to its hypoglycemic potential. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Prior heart conditions should be disclosed to your physician before commencing treatment. Its suitability for pregnant or breastfeeding individuals requires medical consultation. Regular blood glucose monitoring and potential blood tests (blood cell counts, liver function) may be recommended by your doctor.

Uses of Glimbeat M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimbeat M 1mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Glimbeat M 1mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

Common Side effects of Glimbeat M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimbeat M 1mg/500mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimbeat M 1mg/500mg Tablet with a meal.

How Glimbeat M 1mg/500mg Tablet works:

Glimepiride and Metformin 1mg/500mg (Glimbeat M) tablets combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, impeding intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glimbeat M 1mg/500mg tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Glimbeat M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Consult your doctor for guidance.

Breast feedingBreast feedingUNSAFE

Lactation and Glimbeat M 1mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimbeat M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Glimbeat M 1mg/500mg tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimbeat M 1mg/500mg Tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, initiate treatment with a low Glimbeat M 1mg/500mg Tablet dose; however, it's contraindicated in patients with severe liver dysfunction.

What if you forget to take Glimbeat M 1mg/500mg Tablet :

Should you forget a Glimbeat M 1mg/500mg Tablet dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimbeat M 1mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimbeat M 1mg/500mg Tablet

Maintain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Lactic acidosis, a serious medical condition resulting from excessive blood lactic acid, is a potential adverse effect of Glimbeat M 1mg/500mg Tablet. Also termed metformin-associated lactic acidosis (MALA), this rare but severe complication makes the medication unsuitable for individuals with kidney impairment, the elderly, or those who consume significant amounts of alcohol. Characteristic symptoms include muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, and bradycardia. Should these symptoms arise, discontinue Glimbeat M 1mg/500mg Tablet use and seek immediate medical attention.
Glimepiride and Metformin, combined as Glimbeat M 1mg/500mg tablets, manage type 2 diabetes mellitus (DM) in adults. This dual therapy enhances blood sugar control when coupled with a healthy diet and regular physical activity. Glimepiride's mechanism involves stimulating insulin secretion from the pancreas, thus reducing blood glucose. Metformin acts by decreasing hepatic glucose production and boosting insulin responsiveness. This formulation is unsuitable for treating type 1 DM.
Glimbeat M 1mg/500mg Tablets may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, and headache. Rare but potentially serious adverse reactions such as lactic acidosis may occur. Prolonged administration can result in vitamin B12 deficiency.
Indeed, prolonged Glimbeat M 1mg/500mg Tablet use can lead to Vitamin B12 deficiency. This medication disrupts Vitamin B12 absorption in the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications including paresthesia in the extremities, weakness, urinary dysfunction, cognitive impairment, and gait instability. Prophylactic annual Vitamin B12 supplementation is recommended by some studies to mitigate these risks.
Indeed, Glimbeat M 1mg/500mg tablets can induce hypoglycemia. Low blood sugar manifests as nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, strenuous physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Always carry a rapidly absorbable sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimbeat M 1mg/500mg tablets and alcohol is unsafe due to the risk of significantly reduced blood sugar (hypoglycemia) and a heightened probability of lactic acidosis.
Glimbeat M 1mg/500mg Tabl...
37
MRP 45
17% off